Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

BACKGROUND: The present study investigated the efficacy and safety of nivolumab in pre-treated patients with advanced NSCLC harbouring KRAS mutations. METHODS: Clinical data and KRAS mutational status were analysed in patients treated with nivolumab within the Italian Expanded Access Program. Object...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Cancer
Egile Nagusiak: Passiglia, Francesco, Cappuzzo, Federico, Alabiso, Oscar, Bettini, Anna Cecilia, Bidoli, Paolo, Chiari, Rita, Defferrari, Carlotta, Delmonte, Angelo, Finocchiaro, Giovanna, Francini, Guido, Gelsomino, Francesco, Giannarelli, Diana, Giordano, Monica, Illiano, Alfonso, Livi, Lorenzo, Martelli, Olga, Natoli, Clara, Puppo, Gianfranco, Ricevuto, Enrico, Roca, Elisa, Turci, Daniele, Galetta, Domenico
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2018
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325128/
https://ncbi.nlm.nih.gov/pubmed/30377342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0234-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak